Coherence Breathing Before Cardiopulmonary Exercise Testing
Acute Effects of Coherence Breathing on Cardiopulmonary Exercise Responses in Recreationally Active Adults: A Randomized Crossover Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
This randomized crossover trial will examine the acute effects of pre-exercise coherence breathing on cardiopulmonary exercise responses in recreationally active adults. Participants will complete two experimental conditions in randomized order: 5 minutes of guided coherence breathing and 5 minutes of quiet seated spontaneous breathing. Following each condition, participants will perform a standardized treadmill warm-up and a maximal cardiopulmonary exercise test. Outcomes will include oxygen consumption, heart rate, heart rate recovery, perceived exertion, time to completion, and heart rate variability. The findings may help determine whether coherence breathing can serve as an effective autonomic priming strategy before a bout of maximal exercise
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 10, 2026
CompletedStudy Start
First participant enrolled
June 11, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 6, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 6, 2026
June 18, 2026
June 1, 2026
3 months
June 10, 2026
June 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peak Oxygen consumption
Peak oxygen consumption measured during the maximal cardiopulmonary exercise test (CPET) using a portable metabolic analyzer (Vo2 Master)
during each maximal exercise test immediately after the breathing condition
Secondary Outcomes (4)
rating of perceived exertion (RPE)
measured at baseline, during the exercise test and after recovery
Heart Rate Recovery
difference between peak HR during CPET and HR at minute 1, minute 2 and minute 5 of recovery.
Time to completion of maximal exercise test
during the exercise test
Peak Heart Rate
measured during the maximal exercise test
Study Arms (2)
Coherence Breathing
EXPERIMENTALParticipants complete 5 minutes of guided coherence breathing
Spontaneous Breathing
ACTIVE COMPARATORParticipants sit quietly for 5 minutes with spontaneous breathing
Interventions
Participants complete 5 minutes of guided coherence breathing which consists or around 6 breathing cycles (5 seconds inhale and 5 seconds exhale)
Participants sit quietly for 5 minutes with their regular spontaneous breathing
Eligibility Criteria
You may qualify if:
- Adults aged 19 to 45 years.
- Any biological sex.
- Recreationally active, defined as accumulating at least 3 hours per week of moderate-to-vigorous physical activity.
- Able to perform maximal cardiopulmonary exercise testing on a treadmill.
- Able to provide informed consent.
- Cleared for moderate-to-vigorous physical activity based on the PAR-Q+ (or PAR-Q 2023).
You may not qualify if:
- Accumulate less than 3 hours per week of moderate-to-vigorous physical activity.
- Presence of a health condition that contraindicates maximal exercise testing, including:
- Cardiovascular disease. Pulmonary disease. Metabolic disorders. Neuromuscular disorders. Orthopedic limitations that impair exercise performance.
- Acute illness that would interfere with participation or exercise testing.
- Inability or unwillingness to complete study procedures.
- Inability or unwillingness to provide informed consent.
- Not cleared for moderate-to-vigorous physical activity based on the PAR-Q+ (or PAR-Q+ 2023).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Monmouth University Graduate Center, Human Performance Lab, Room 222
West Long Branch, New Jersey, 07764, United States
Related Publications (3)
Trinkunas E, Kairiukstiene Z, Trinkunaite M, Poderiene K, Brazdzionyte R, Poderys J. Post-Exercise Controlled Breathing Enhances Cardiovascular Recovery and Autonomic Balance: A Randomised Crossover Study. Medicina (Kaunas). 2026 Feb 3;62(2):318. doi: 10.3390/medicina62020318.
PMID: 41752717BACKGROUNDLaborde S, Allen MS, Borges U, Dosseville F, Hosang TJ, Iskra M, Mosley E, Salvotti C, Spolverato L, Zammit N, Javelle F. Effects of voluntary slow breathing on heart rate and heart rate variability: A systematic review and a meta-analysis. Neurosci Biobehav Rev. 2022 Jul;138:104711. doi: 10.1016/j.neubiorev.2022.104711. Epub 2022 May 24.
PMID: 35623448BACKGROUNDSevoz-Couche C, Laborde S. Heart rate variability and slow-paced breathing:when coherence meets resonance. Neurosci Biobehav Rev. 2022 Apr;135:104576. doi: 10.1016/j.neubiorev.2022.104576. Epub 2022 Feb 12.
PMID: 35167847BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2026
First Posted
June 16, 2026
Study Start
June 11, 2026
Primary Completion (Estimated)
September 6, 2026
Study Completion (Estimated)
October 6, 2026
Last Updated
June 18, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share